| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/09/2003 | EP1299528A1 Human olfactory receptors and genes encoding same |
| 04/09/2003 | EP1299522A2 Alteration of cell membrane |
| 04/09/2003 | EP1299417A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/09/2003 | EP1299415A1 Chemokine receptor modulators, production and use |
| 04/09/2003 | EP1299414A2 Fluorescent proteins |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1299410A2 GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 04/09/2003 | EP1299327A2 Phosphorylated polypeptides and uses related thereto |
| 04/09/2003 | EP0804552B1 Redirection of cellular immunity by receptor chimeras |
| 04/09/2003 | CN1408880A Detecting and trapping receptor 3 monoclonal antibody, hybrid tumor for producing said antibody and its use |
| 04/09/2003 | CN1105187C Protocadherin proteins and their use |
| 04/08/2003 | US6545142 Primers; nucleotide sequence |
| 04/08/2003 | US6545124 Antiproliferative agents |
| 04/08/2003 | US6544784 Multiple-tumor aberrant growth genes |
| 04/08/2003 | US6544731 Genetic engineering; binding antibodies |
| 04/08/2003 | US6544522 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 04/03/2003 | WO2003027252A2 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
| 04/03/2003 | WO2003026700A2 Compositions for transporting antibodies through the blood brain barrier and their use for diagnosing or treating central nervous system diseases |
| 04/03/2003 | WO2003026490A2 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules |
| 04/03/2003 | WO2002066649A3 ANTI-INTERFERON-α ANTIBODIES |
| 04/03/2003 | WO2002059256A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/03/2003 | WO2002057413A3 Peptides for activation and inhibition of delta pkc |
| 04/03/2003 | WO2002024909A9 Receptor nucleic acids and polypeptides |
| 04/03/2003 | WO2002014369A9 Human kininogen d5 domain polypeptides and their use |
| 04/03/2003 | WO2001072769A9 Methods for purifying highly anionic proteins |
| 04/03/2003 | US20030064078 Vaccines |
| 04/03/2003 | US20030064063 For prophylaxis of type I hypersensitivity disease in a subject receiving immunotherapy |
| 04/03/2003 | CA2461631A1 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules |
| 04/02/2003 | EP1298215A2 Recombinant production of immunologically reactive truncated CMV glycoprotein H |
| 04/02/2003 | EP1298144A2 Murine monoclonal anti-idiotype antibody 3H1 |
| 04/02/2003 | EP1297161A2 Methods and means for regulation of gene expression |
| 04/02/2003 | EP1297147A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 04/02/2003 | EP1297144A1 Recombinant saccharomyces cerevisiae expressing chimeric glucose transporters |
| 04/02/2003 | EP1297133A2 Gp354 nucleic acids and polypeptides |
| 04/02/2003 | EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 04/02/2003 | EP1297118A1 Prostase protein vaccine comprising derivatised thiol residues and methods for producing said antigen |
| 04/02/2003 | EP1297014A2 Transporters and ion channels |
| 04/02/2003 | EP1297013A2 Use of taci as an anti-tumor agent |
| 04/02/2003 | EP1297012A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 04/02/2003 | EP0700444B1 Immunotoxins comprising gelonin and an antibody |
| 04/02/2003 | EP0673427B1 Enzymatic process using enzymes immobilized on the cell wall of a eukaryotic microbial cell by producing a fusion protein |
| 04/01/2003 | US6541619 Genetic engineering; transforming Escherichia culture product; anticancer agent |
| 04/01/2003 | US6540992 Elk ligand (Elk-L) where elk is a member of the tyrosine kinase receptor family; protects against excitotoxicity, especially of the hipocammpal neurons |
| 04/01/2003 | CA2101070C Antigen-presenting capsid with fusion ms2-coat protein |
| 03/27/2003 | WO2003025016A2 Trk polypeptide purification method |
| 03/27/2003 | WO2003024392A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/27/2003 | WO2003000732A3 Fragments of the retinoic acid-related orphan receptor (ror) comprising the lig and binding domain (lbd), crystal structure of the lbd of ror-beta and their applications |
| 03/27/2003 | WO2002055992A3 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof |
| 03/27/2003 | WO2002053761A3 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 03/27/2003 | WO2002048358A3 Regulation of human chemokine-like receptor |
| 03/27/2003 | WO2002031512A3 Molecular interactions in hematopoietic cells |
| 03/27/2003 | WO2002026951A3 Oxidoreductases |
| 03/27/2003 | WO2002022684A3 Transporters and ion channels |
| 03/27/2003 | US20030060616 Type II IL-1 receptors |
| 03/27/2003 | US20030059937 Antibodies that immunospecifically bind BLyS |
| 03/27/2003 | US20030059921 Novel clot-specific steptokinase proteins possessing altered plasminogen activation characteristics and a process for the preparation of said proteins |
| 03/27/2003 | US20030059910 Oil bodies and associated proteins as affinity matrices |
| 03/27/2003 | US20030059835 Nucleotide sequence coding red fluorescent protein for use as diagnostic tool in genetic analysis |
| 03/27/2003 | US20030059461 Molecular delivery vehicle for delivery of selected compounds to targets |
| 03/27/2003 | US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 03/27/2003 | CA2460706A1 Trk polypeptide purification method |
| 03/27/2003 | CA2460120A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/26/2003 | EP1294908A1 Method for improving transfection efficiency |
| 03/26/2003 | EP1294905A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest |
| 03/26/2003 | EP1294893A2 Modification of hepatitis b core antigen |
| 03/26/2003 | EP1294892A2 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 03/26/2003 | EP1294885A2 B7-like molecules and uses thereof |
| 03/26/2003 | EP1294882A2 B7-like molecules and uses thereof |
| 03/26/2003 | EP1294879A2 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 03/26/2003 | EP1294873A1 Tumour suppressor and uses thereof |
| 03/26/2003 | EP1294871A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
| 03/26/2003 | EP1294868A2 Adenylyl and guanylyl cyclases |
| 03/26/2003 | EP1294770A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 03/26/2003 | EP1294769A1 Antibodies that immunospecifically bind to blys |
| 03/26/2003 | EP1294765A2 Il-17 molecules and uses thereof |
| 03/26/2003 | EP1294755A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 03/26/2003 | EP1294752A2 Angiogenesis-modulating compositions and uses |
| 03/26/2003 | EP1294748A2 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same |
| 03/26/2003 | EP1294746A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 03/26/2003 | EP1294409A2 Membrane-permeant peptide complexes for medical imaging |
| 03/26/2003 | EP1294401A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 03/26/2003 | EP0833658B1 Inhibin compositions and methods of enhancing production performance |
| 03/26/2003 | EP0759037B1 Antigen/antibody specificity exchanger |
| 03/26/2003 | EP0610436B9 Hepatitis-c virus testing |
| 03/26/2003 | CN1406280A Progenitor cell preservation factors and related methods and products |
| 03/26/2003 | CN1406249A Enhancing the circulating half-life of antibody-based fusion proteins |
| 03/26/2003 | CN1405185A Tumour vascular-targeting and novel recombinant human tumour necrosis factor fusion protein and its preparation |
| 03/26/2003 | CN1405184A Anti-small cell lung carcinoma polypeptide mixture |
| 03/26/2003 | CN1405183A Serum albumin and granulocyte-macrophage colony stimulating factor fusion protein |
| 03/26/2003 | CN1405182A 血清白蛋白与粒细胞集落刺激因子的融合蛋白 Serum albumin and granulocyte colony-stimulating factor fusion protein |
| 03/26/2003 | CN1405181A Serum albumin and interferon fusion protein |
| 03/25/2003 | US6538127 Synthetic HIV-2 envelope genes containing modifications that lead to optimized expression in bacteria |
| 03/25/2003 | US6538126 Polynucleotides of given sequence derived from CDNA |
| 03/25/2003 | US6538113 Methods of obtaining antibody directed against prothrombin fragments F2/F1+2 |
| 03/25/2003 | US6538103 Anti-angiogenic agents; kringle 1; use treatment of cancer, diabetic retinopathy, rheumatoid arthritis, psoriasis, arteriosclerotic plaque formation |
| 03/25/2003 | US6537794 Chemokine |
| 03/25/2003 | US6537556 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation process |
| 03/25/2003 | US6537555 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 03/25/2003 | US6537519 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 03/20/2003 | WO2003022990A2 Production of fusion proteins and use for identifying binding molecules |